Nucleai
Tel Aviv, Israel · nucleai.ai
ISO 13485 · CLIA
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Nucleai develops an AI-driven tissue intelligence platform for biopharma drug development. It supports translational research and clinical development by analyzing tissue data and linking it to clinical outcomes for programs in oncology, immunology and inflammation, neurology, and metabolic disease. The company is based in Tel Aviv, Israel.
Their website has a general contact form; we send your quote request through it.
What they offer
Translational Research
Supports discovery and translational programs from early signal and mechanistic understanding through biomarker discovery, threshold-setting, and validation against clinical outcomes.
Clinical Development & Companion Diagnostics
Supports patient selection in trials and companion diagnostic development with validated spatial biomarkers and deployable scoring algorithms under design controls.
AI-powered tissue analysis platform
Extracts structured, reproducible spatial features from H&E, IHC, multiplex imaging, and spatial transcriptomics and links them to clinical questions and outcomes.
Multimodal tissue analysis
Analyzes H&E, IHC, multiplex fluorescence, and spatial transcriptomics in a unified patient-level dataset.
Virtual multiplexing
Registers serial H&E, IHC, and mIF sections into one reconstructed view to estimate cell-level co-expression without staining the same section twice.
Cross-modal prediction
Infers higher-cost readouts directly from routine H&E.
Spatial feature extraction
Identifies segmentation, quantification, neighborhood, proximity, and immune-contexture features from tissue images.
Biomarker scoring and validation
Measures tissue features such as H-score, percent positivity, TILs, and Spatial Proximity Score, with validation against clinical endpoints.
What they work on
- Modalities
- Small molecule, Antibody, Bispecific, ADC
- Assays and studies
- cell typing, area segmentation, neighbor discovery, continuous per-cell marker scoring, quantitative optical density scoring, co-expression analysis, spatial proximity analysis, virtual multiplexing, cross-modal integration, predictive biomarker modeling
- Instruments and platforms
- CLIA lab viewer
- Scale and capacity
- 30+ clinical trials, 10+ indications, over 1,000 features per mIF sample, over 500 features from H&E alone
- Therapeutic areas
- oncology, immunology and inflammation, neurology, metabolic disease
- Sites
- Tel Aviv, Israel
- Quality
- ISO 13485 compliant quality management s (design controls / products developed and deployed under risk-based implementation) · ISO/IEC 27001 compliant information secu · CLIA/CAP-certified partner labs (validated path to CDx deployment)
Similar labs. 3C Therapeutics, AGC Biologics, AlphaThera, Anthem
Found in a contract services directory. Listing built from nucleai.ai. Work here? Claim this listing.